Therefore, the current study will open new avenue to investigate the role of S‐nitrosylation in Akt functional regulation and also provide some insights to drug design for improving cardiac dysfunction in that targeting Akt S‐nitrosylation to improve the outcome of patients with MI. This evidence concerns the gene AKT1 and myocardial infarction.